Hawkins, Inc. (HWKN)
適正価値ファンダメンタル
62
株価
$125.88
時価総額
$2.63B
パート1 · 企業の価値
概要
Hawkins, Inc. is a US specialty chemical company that formulates, manufactures, blends and distributes chemicals and ingredients through three segments: Water Treatment, Food and Health Sciences and Industrial Solutions. Its largest business supplies municipalities, wastewater plants and pool operators with treatment chemicals, filtration media, systems and equipment, delivered from a dense local network of 53 warehouses across 28 states, mostly in the eastern United States. The other two businesses distribute and process ingredients for the nutrition, food, pharmaceutical and agricultural markets, and supply bulk industrial chemicals such as caustic soda and sulfuric acid to manufacturers. Fiscal 2026 ended on March 29, 2026, with sales of $1,083.7 million and about 1,200 employees; the company describes 17 acquisitions completed over the last five years, mostly to build out Water Treatment.
収益の仕組み
Hawkins earns revenue by selling physical product: chemicals it buys in bulk, receives by rail or truck, then repackages, blends or formulates and delivers to the customer, plus filtration media, equipment and systems in water treatment. Revenue is essentially transactional and volume-driven rather than contractual or subscription-based, with gross margin coming from the spread between raw-material cost and the delivered price of a formulated or repackaged product; fiscal 2026 gross profit was $245.1 million, or 23% of sales. Growth comes from a mix of volume, price and acquisitions — of the $96.8 million increase in Water Treatment sales in fiscal 2026, $83.3 million came from businesses acquired during the year.
セグメント別売上高
Sells treatment chemicals, filtration media, systems and equipment for potable water, wastewater and swimming pools, mainly to municipalities and pool operators, delivered from 53 warehouses in 28 states. Fiscal 2026 sales were $543.3 million, up 22%.
Distributes and processes ingredients — vitamins, minerals, botanicals, sweeteners and food-grade salts — for the nutrition, food, pharmaceutical and agricultural markets. Fiscal 2026 sales were $320.7 million, down 1% on softness in food and nutrition end markets.
Supplies bulk and repackaged industrial chemicals such as acids, alkalis, caustic soda and sulfuric acid to manufacturing, electronics, energy and metal-plating customers. Fiscal 2026 sales were $219.7 million, up 7%.
競争優位性(moat)
明確な優位性なし · なしThe company's own filing undercuts the case for a durable advantage: it says it competes with many producers, distributors and sales agents offering products equivalent to substantially all of the products it offers, and that many competitors are larger with greater financial resources. What it claims instead is service-based — quality products, customer service, competitive prices, value-added formulation, and long-standing supplier relationships that help it secure product during supply constraints. Its local depth in water treatment (53 warehouses in 28 states) makes it hard for a distant rival to serve the same small municipality economically, but that is a regional density effect on commodity chemistry, not a pricing power the filing anywhere demonstrates.
需要を左右する要因
中程度の景気循環性The mix splits the cycle in two. Half of revenue is Water Treatment, where municipal potable-water and wastewater plants must keep dosing chemicals whatever the economy does — a defensive, budget-funded demand that varies more with weather and the April-to-September season than with GDP. Industrial Solutions, a fifth of revenue, sells into manufacturing, electronics, energy and plating, and the company itself lists a risk factor stating that demand for its products is affected by general economic conditions and the cyclical nature of the industries it serves. Food and Health Sciences sits in between, exposed to nutrition and food end-market demand, which softened in fiscal 2026, and to planting seasons on the agricultural side.
主なリスク
- Competition and price pressure — The company operates in a competitive environment against producers, distributors and sales agents offering equivalent products, many of them larger and better financed, which exposes it to significant price pressure.
- Raw-material prices and availability — Results depend on fluctuations in the price and availability of the chemicals and ingredients Hawkins buys; the filing also flags disruptions within the supply chain and dependence on transportation infrastructure to move product.
- Seasonality and weather — Water Treatment and agricultural sales are seasonal and weather-sensitive: precipitation or temperatures higher or lower than normal change water usage, and agricultural sales follow planting seasons. Water Treatment historically sells more from April to September.
- Hazards of handling chemicals — The business is subject to hazards common to chemical operations, to product liability claims and recalls, and to environmental problems at its facilities; insurance may not fully cover all potential exposures.
- Acquisitions may not deliver — The company may not successfully consummate future acquisitions or dispositions, and lists impairment to the carrying value of goodwill or other intangible assets as a risk — relevant for a group that completed 17 acquisitions in five years.
- Regulation, tariffs and covenants — Environmental, health, safety and transportation laws impose substantial costs, many products are subject to government regulation, tariffs or trade-policy changes could have a substantial effect, and failure to comply with credit facility covenants is listed as a risk.
- Cybersecurity and key personnel — The company cites failure to adequately protect critical data and technology systems, and the possibility of being unable to retain key personnel or attract skilled personnel, among its disclosed risk factors.
顧客集中度
The filing states that in fiscal 2026, 2025 and 2024 none of its customers accounted for 10% or more of total sales. It does not disclose a combined share for the top customers, so no number can be given; the disclosure is consistent with a fragmented base of municipalities, food and nutrition processors and industrial accounts.
強気材料
Buyers argue that Hawkins has turned a commodity distribution business into something steadier by concentrating on water treatment, which now makes up half of revenue and grew 22% in fiscal 2026 to $543.3 million. Municipal water and wastewater demand is funded by public budgets and does not disappear in a recession, and the local warehouse network makes the company the practical supplier for small utilities. They point to the acquisition machine — 17 deals in five years, $83.3 million of acquired sales added in fiscal 2026 alone — as a repeatable way to buy small regional operators and plug them into an existing route network, and to the fact that the group crossed $1 billion of revenue for the first time while adjusted EBITDA rose 6% to $179.0 million. No customer reaches 10% of sales, and management guided to revenue and operating income growth across all three segments in fiscal 2027 with leverage coming down toward roughly 1x adjusted EBITDA.
弱気材料
Sellers fear that the growth is bought rather than earned: revenue rose 11% in fiscal 2026 but diluted earnings per share fell 3%, from $4.03 to $3.91, while gross margin stayed at 23% of sales — the deals are adding revenue faster than they add per-share profit, and the filing lists goodwill and intangible impairment among its risks. Strip out acquisitions and Water Treatment's organic growth is a fraction of the reported 22%; Food and Health Sciences actually shrank 1% on soft food and nutrition end markets. They also note that the company describes its own market as one where competitors offer equivalent products and many are larger and better financed, which caps pricing power, and that earnings are hostage to raw-material prices, freight, weather and the April-to-September water season. Integrating 17 acquisitions in five years, including the $149.9 million WaterSurplus deal, carries execution and leverage risk that a single bad season or a covenant problem could expose.
Generated on 2026年9月18日 with claude-haiku-4-5 — shared with all users
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
貸借対照表と流動性
売上高
$1.11B
直近12か月(2026/6/28まで)
純利益
$81M
直近12か月(2026/6/28まで)
フリーキャッシュフロー
$86M
自己資本合計
$534M
負債合計
$452M
流動比率
2.27
利払い倍率
9.12
負債/EBITDA
1.50
一株当たり利益(EPS)
売上高と純利益
フリーキャッシュフロー
収益内訳
財務推移表
利益率の推移
負債の推移
負債の重さ
成長率グリッド
成長率 — 売上高
適正価値の推定
適正価値
$111.09
現在株価
$125.88
安全マージン
-13.3%
適正価値レンジ
$72.21 - $149.98
使用した評価手法間のばらつきであり、統計的に較正された信頼区間ではありません。
推定方法
バリュエーション指標
P/E レシオ
32.64
ROE
15.3%
P/B レシオ
4.80
P/FCF
28.69
粗利益率
22.3%
ROIC
10.4%
収益性レーダー
価値創造(経済的モート)
ROIC
10.4%
WACC
8.2%
ROIC − WACC
+2.2 pp
ROICが資本コストを上回っています。企業は株主のために価値を創出しています。
ファンダメンタル分析基準
合格(16)
- EPS shows upward trend
- Price CAGR 16.48%
- ROIC 10.5%
- P/FCF 28.69
- Debt/Equity ratio
- Operating Margin 10.7%
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 15.3%
- Revenue Growth 5Y 12.7%
- Analyst Consensus 78% Buy
- Earnings Quality (OCF/NI) 1.84
- Share Dilution -0.3%
不合格(11)
- EPS CAGR 3.32%
- Gross Margin 22.3%
- P/B Ratio 4.80
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Earnings Surprise avg -8.1%
- PEG Ratio 2.15
- Net Margin Trend 7.3% vs 8.4%
- Piotroski F-Score 4/9
データなし(1)
- Dividend Payout NaN%
Piotroski F-スコア
まちまちのシグナル:一部の領域に注意が必要
利益の質
高品質:利益はキャッシュに裏付けられている
株式希薄化
株式を買い戻している。株主に友好的
機関投資家の保有
ガバナンス
経営陣
| 氏名 | 役職 | 年齢 |
|---|---|---|
| Mr. Patrick H. Hawkins | CEO, President & Director | 54 |
| Mr. Jeffrey P. Oldenkamp | Executive VP, CFO & Treasurer | 53 |
| Mr. Drew M. Grahek | Vice President of Operations | 55 |
| Mr. Daniel J. Stauber | Director | 63 |
| Mr. David J. Mangine | Vice President of Industrial Solutions | 67 |
| Mr. Douglas A. Lange | Vice President of Water Treatment Group | 55 |
| Mr. Daniel A. Louismet | VP, General Counsel & Secretary | 39 |
| Mr. Paul Siler | Corporate Controller | - |
監査リスク
7
取締役会リスク
3
報酬リスク
3
株主権利リスク
4
パート2 · 株価と買い時
この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容:テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。
業績推移
via SEC EDGAR
Latest News
Recent headlines for HWKN, sourced from Markets Gazette.